0001968582-23-000736.txt : 20231201 0001968582-23-000736.hdr.sgml : 20231201 20231201192435 ACCESSION NUMBER: 0001968582-23-000736 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20231201 DATE AS OF CHANGE: 20231201 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Apellis Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001492422 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 271537290 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-38276 FILM NUMBER: 231460975 BUSINESS ADDRESS: STREET 1: 100 FIFTH AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-977-5700 MAIL ADDRESS: STREET 1: 100 FIFTH AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Dunlop A. Sinclair CENTRAL INDEX KEY: 0001721108 FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O APELLIS PHARMACEUTICALS, INC. STREET 2: 6400 WESTWIND WAY, SUITE A CITY: CRESTWOOD STATE: KY ZIP: 40014 144 1 primary_doc.xml 144 0001721108 XXXXXXXX LIVE 0001492422 Apellis Pharmaceuticals, Inc. 001-38276 100 Fifth Avenue Waltham MA 02451 617-977-5700 A. Sinclair Dunlop Director Common Stock JP Morgan Securities LLC

390 Madison Avenue 6th Floor New York NY 10017

24000 1295760 118499945 12/01/2023 NASDAQ Common Stock 12/21/2012 Private Transaction Issuer N 24000 12/21/2012 N/A N Epidarex Capital I, LP

C/o Apellis Pharmaceuticals, Inc. 100 Fifth Avenue Waltham MA 02451

Common Stock 11/17/2023 24000 1176000 The shares filed today will be sold by Epidarex Capital I, LP, A. Sinclair Dunlop as Managing Partner 12/01/2023 /s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for A. Sinclair Dunlop